AgeX Therapeutics, Inc. (AGE)

R&D Expenses

$14.07M

TTM · Period ending: · USD

AGE logo

AGE R&D Expenses

Latest reported$14.07M
AGE R&D Expenses ($5.78M → $14.07M)
High-resolution chart · PNG

AGE r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
13,155,000
7,480,000
603,000
1,025,000
1,456,000
4,978,000
5,904,000
6,630,000
5,784,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.